Compare INDV & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDV | CSTM |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | France |
| Employees | N/A | 11500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.4B |
| IPO Year | 2014 | 2012 |
| Metric | INDV | CSTM |
|---|---|---|
| Price | $41.18 | $29.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $30.75 |
| AVG Volume (30 Days) | ★ 1.6M | 1.6M |
| Earning Date | 06-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | 405.26 |
| EPS | 0.69 | ★ 1.42 |
| Revenue | $1,239,000,000.00 | ★ $8,449,000,000.00 |
| Revenue This Year | N/A | $21.46 |
| Revenue Next Year | N/A | $0.50 |
| P/E Ratio | $57.96 | ★ $21.26 |
| Revenue Growth | 4.29 | ★ 15.19 |
| 52 Week Low | $15.00 | $13.04 |
| 52 Week High | $42.81 | $36.99 |
| Indicator | INDV | CSTM |
|---|---|---|
| Relative Strength Index (RSI) | 63.02 | 38.47 |
| Support Level | $35.36 | $28.39 |
| Resistance Level | $42.81 | $31.20 |
| Average True Range (ATR) | 1.50 | 1.30 |
| MACD | -0.00 | -0.51 |
| Stochastic Oscillator | 67.31 | 15.12 |
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.